Integration of magnet and components in progressGE Medical has upgraded its Logiq 700 ultrasound system with a new coding system invented to boost the intensity of deep body signals.GE started shipping upgrades of what it has named "digitally
Integration of magnet and components in progress
GE Medical has upgraded its Logiq 700 ultrasound system with a new coding system invented to boost the intensity of deep body signals.
GE started shipping upgrades of what it has named "digitally encoded ultrasound" technology to its installed base at the end of May. Jeff Peiffer, manager of America's ultrasound marketing for GE, said his company has patented the coding for the ultrasound system. The Logiq 700 was introduced in the spring of 1999.
The new coding expands B-Flow imaging to more transducers. GE's B-Flow allows clinicians to image blood vessel walls and blood flow. With the new coding, B-Flow can now show difficult-to-image parts of the anatomy because of the coding's ability to transmit signals with specially designed codes, said Peiffer. For example, a fetal umbilical cord and heart may be imaged with B-Flow using GE's new coding, Boesen said.
"We are able to boost weak signals and suppress unwanted noise," said Pete Boesen, GE Medical marketing manager for radiology ultrasound.
Boesen and Peiffer noted that medical imaging companies started using B-Flow a year ago for blood imaging. Now the technique can be used with seven probes available for GE's Logiq 700.
GE's package also comes with new transducers and three other enhancements: virtual convex imaging, which extends the linear and sector transducers' fields of view while maintaining fine detail resolution; Logiq View, which captures an expanded length of anatomy in each view in gray-scale, color Doppler, and power Doppler imaging modes; and pulsatile flow detection, a method that streamlines blood vessel exams by differentiating pulsatile from nonpulsatile flow.
GE showcased Logic View as a work-in-progress at the RSNA meeting last year (SCAN 1/12/00).
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.